Safety and Efficacy of AIV001 on Low Risk Basal Cell Carcinoma

Conditions:   Superficial Basal Cell Carcinoma;   Nodular Basal Cell Carcinoma Intervention:   Drug: AIV001 Sponsor:   AiViva BioPharma, Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials